CoreCap Advisors’s Anixa Biosciences ANIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $154K | Buy |
46,787
+2,000
| +4% | +$6.6K | 0.01% | 834 |
|
|
2025
Q1 | $128K | Hold |
44,787
| – | – | 0.01% | 817 |
|
|
2024
Q4 | $104K | Hold |
44,787
| – | – | ﹤0.01% | 916 |
|
|
2024
Q3 | $141K | Sell |
44,787
-2,107
| -4% | -$6.64K | 0.01% | 795 |
|
|
2024
Q2 | $104K | Buy |
46,894
+2,600
| +6% | +$5.75K | 0.01% | 489 |
|
|
2024
Q1 | $138K | Buy |
+44,294
| New | +$138K | 0.01% | 735 |
|
|
2022
Q4 | $154K | Sell |
36,209
-1,177
| -3% | -$5K | 0.01% | 596 |
|
|
2022
Q3 | $184K | Buy |
37,386
+250
| +0.7% | +$1.23K | 0.02% | 492 |
|
|
2022
Q2 | $114K | Sell |
37,136
-480
| -1% | -$1.47K | 0.01% | 648 |
|
|
2022
Q1 | $103K | Buy |
37,616
+2,664
| +8% | +$7.3K | 0.01% | 535 |
|
|
2021
Q4 | $104K | Buy |
+34,952
| New | +$104K | 0.01% | 730 |
|